West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 796,300 | 886,300 | 894,300 | 729,000 | 718,500 |
| Receivables | 534,400 | 513,400 | 507,400 | 485,300 | 528,400 |
| Inventories | 449,400 | 447,000 | 414,800 | 413,100 | 411,600 |
| Other current assets | 94,100 | 90,500 | 103,000 | 106,200 | 112,600 |
| TOTAL | $1,874,200 | $1,937,200 | $1,919,500 | $1,733,600 | $1,771,100 |
| Non-Current Assets | |||||
| PPE Net | 1,261,300 | 1,215,200 | 1,158,300 | 1,069,000 | 1,077,400 |
| Investments And Advances | 202,800 | 208,800 | 204,900 | 188,600 | 193,300 |
| Intangibles | 124,800 | 125,600 | 125,700 | 122,100 | 126,600 |
| Other Non-Current Assets | 206,500 | 236,800 | 208,400 | 203,500 | 193,300 |
| TOTAL | $1,795,400 | $1,786,400 | $1,697,300 | $1,583,200 | $1,590,600 |
| Total Assets | $3,669,600 | $3,723,600 | $3,616,800 | $3,316,800 | $3,361,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 218,000 | 233,800 | 215,400 | 188,900 | 220,000 |
| Accrued Expenses | 112,100 | 65,700 | 101,600 | 66,700 | 78,800 |
| Other current liabilities | 163,100 | 158,000 | 183,800 | 155,700 | 179,100 |
| TOTAL | $511,600 | $534,900 | $519,000 | $456,700 | $565,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 205,600 | 206,100 | 206,700 | 207,200 | 207,800 |
| aiOther Non-Current Liabilities | 169,700 | 172,900 | 172,800 | 146,300 | 141,800 |
| TOTAL | $411,300 | $412,500 | $412,900 | $389,300 | $372,200 |
| Total Liabilities | $922,900 | $947,400 | $931,900 | $846,000 | $937,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,861 | 74,243 | 74,136 | 74,033 | 74,048 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 3,254,600 | 3,113,600 | 2,987,800 | 2,913,100 | 2,792,500 |
| Other shareholders' equity | -183,900 | -168,600 | -182,900 | -308,700 | -246,200 |
| TOTAL | $2,746,700 | $2,776,200 | $2,684,900 | $2,470,800 | $2,424,400 |
| Total Liabilities And Equity | $3,669,600 | $3,723,600 | $3,616,800 | $3,316,800 | $3,361,700 |